We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Therapies Targeting Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

Whitepaper  
Published: December 9, 2022
 
Therapies Targeting Myeloid-Derived Suppressor Cells in the Tumor Microenvironment content piece image

Studying the tumor microenvironment (TME) helps improve our understanding of cancer. Myeloid-derived suppressor cells (MDSCs) exist within the TME and maintain cancer progression. MDSCs can be used as prognostic markers and potential therapeutic targets to eliminate immunosuppressive activities and enhance antitumor immune responses.


Download this whitepaper to learn more about immunotherapy strategies including:


  • Depletion of MDSC populations and infiltration
  • Inhibition of MDSC recruitment and transport
  • Anticytokine therapy of MDSCs
Related Topic Pages
The Immune System
Cancer Immunology
Spatial Biology
Advertisement
Chosen for You
Dr. Khadijah A. Mitchell
Article

Cancer Research, Mentorship and Confidence in Your Competence With Dr. Khadijah A. Mitchell
A lab worker pipetting media into a cell culture dish.
Industry Insight

Recreating Organ-Specific Tumor Environments In Vitro
A microplate containing tumoroids, zoomed in image of the individual wells and further magnification of the GEP-NENs tumoroid
Article

Unveiling Novel Therapeutic Targets for Neuroendocrine Cancers: A Precision Medicine Breakthrough
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter